{
    "nct_id": "NCT04694820",
    "official_title": "txt4TKI: An Innovative Mobile Intervention to Improve Tyrosine Kinase Inhibitor Management Among Chronic Myeloid Leukemia Patients",
    "inclusion_criteria": "* PHASE 1: Patients diagnosed with chronic myeloid leukemia\n* PHASE 1: Initiated tyrosine kinase inhibitors therapy for a year\n* PHASE 1: Able to read and understand English\n* PHASE 1: Able to provide informed consent\n* PHASE 1: Have a mobile phone with TXT capability\n* PHASE 1: Know how to use TXT\n* PHASE 2: Patients diagnosed with chronic myeloid leukemia in the chronic phase\n* PHASE 2: Starting tyrosine kinase inhibitors therapy or has been on tyrosine kinase inhibitors with anticipation of at least 6 month duration of use\n* PHASE 2: Able to read and understand English\n* PHASE 2: Able to provide informed consent\n* PHASE 2: Have a mobile device with TXT capability\n* PHASE 2: Willing to use a wireless pill bottle during study for 6 months\n* PHASE 2: Know or willing to learn how to use TXT\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "â€¢ Cognitive impaired document in the electronic medical record (EMR)",
    "miscellaneous_criteria": ""
}